Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Acquisitions & Divestments: 2021-2025

Historic Change in Acquisitions & Divestments for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $95.8 million.

  • Krystal Biotech's Change in Acquisitions & Divestments rose 20.87% to $95.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $350.4 million, marking a year-over-year increase of 12.07%. This contributed to the annual value of $298.5 million for FY2024, which is 40.67% down from last year.
  • As of Q3 2025, Krystal Biotech's Change in Acquisitions & Divestments stood at $95.8 million, which was down 9.01% from $105.3 million recorded in Q2 2025.
  • Krystal Biotech's 5-year Change in Acquisitions & Divestments high stood at $161.2 million for Q2 2023, and its period low was $1.2 million during Q2 2021.
  • For the 3-year period, Krystal Biotech's Change in Acquisitions & Divestments averaged around $99.2 million, with its median value being $95.2 million (2024).
  • As far as peak fluctuations go, Krystal Biotech's Change in Acquisitions & Divestments soared by 4,992.62% in 2022, and later crashed by 58.83% in 2024.
  • Quarterly analysis of 5 years shows Krystal Biotech's Change in Acquisitions & Divestments stood at $21.0 million in 2021, then surged by 395.73% to $104.1 million in 2022, then declined by 28.33% to $74.6 million in 2023, then dropped by 18.90% to $60.5 million in 2024, then rose by 20.87% to $95.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $95.8 million in Q3 2025, compared to $105.3 million in Q2 2025 and $88.8 million in Q1 2025.